244 related articles for article (PubMed ID: 12724863)
1. Incorporating cytochrome P450 3A4 genotype expression and FT-IR/Raman spectroscopy data as means of identification of breast tumors.
Miller SO; Ewing GP; Howard C; Tachikawa H; Bigler SA; Barber WH; Angel M; McDaniel DO
Biomed Sci Instrum; 2003; 39():24-9. PubMed ID: 12724863
[TBL] [Abstract][Full Text] [Related]
2. Expression of cytochromes P450 in human breast tissue and tumors.
Huang Z; Fasco MJ; Figge HL; Keyomarsi K; Kaminsky LS
Drug Metab Dispos; 1996 Aug; 24(8):899-905. PubMed ID: 8869826
[TBL] [Abstract][Full Text] [Related]
3. RNA expression of cytochrome P450 in breast cancer patients.
Vaclavikova R; Hubackova M; Stribrna-Sarmanova J; Kodet R; Mrhalova M; Novotny J; Gut I; Soucek P
Anticancer Res; 2007; 27(6C):4443-50. PubMed ID: 18214058
[TBL] [Abstract][Full Text] [Related]
4. Raman spectroscopy can differentiate malignant tumors from normal breast tissue and detect early neoplastic changes in a mouse model.
Kast RE; Serhatkulu GK; Cao A; Pandya AK; Dai H; Thakur JS; Naik VM; Naik R; Klein MD; Auner GW; Rabah R
Biopolymers; 2008 Mar; 89(3):235-41. PubMed ID: 18041066
[TBL] [Abstract][Full Text] [Related]
5. Comparative aflatoxin B(1) activation and cytotoxicity in human bronchial cells expressing cytochromes P450 1A2 and 3A4.
Van Vleet TR; Macé K; Coulombe RA
Cancer Res; 2002 Jan; 62(1):105-12. PubMed ID: 11782366
[TBL] [Abstract][Full Text] [Related]
6. A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis.
Modugno F; Knoll C; Kanbour-Shakir A; Romkes M
Breast Cancer Res Treat; 2003 Dec; 82(3):191-7. PubMed ID: 14703066
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer.
Huang CS; Shen CY; Wang HW; Wu PE; Cheng CW
Clin Chim Acta; 2007 Sep; 384(1-2):69-74. PubMed ID: 17651715
[TBL] [Abstract][Full Text] [Related]
8. CYP2C and IL-6 expression in breast cancer.
Knüpfer H; Schmidt R; Stanitz D; Brauckhoff M; Schönfelder M; Preiss R
Breast; 2004 Feb; 13(1):28-34. PubMed ID: 14759713
[TBL] [Abstract][Full Text] [Related]
9. The quantification of cytochrome P-450 (CYP 3A4) mRNA in the blood of patients with viral liver diseases.
Horiike N; Abe M; Kumagi T; Hiasa Y; Akbar SM; Michitaka K; Onji M
Clin Biochem; 2005 Jun; 38(6):531-4. PubMed ID: 15885232
[TBL] [Abstract][Full Text] [Related]
10. Fourier transform infrared and Raman microspectroscopy of materials in tissue.
Kalasinsky VF; Johnson FB; Ferwerda R
Cell Mol Biol (Noisy-le-grand); 1998 Feb; 44(1):141-4. PubMed ID: 9551646
[TBL] [Abstract][Full Text] [Related]
11. Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues.
Bièche I; Narjoz C; Asselah T; Vacher S; Marcellin P; Lidereau R; Beaune P; de Waziers I
Pharmacogenet Genomics; 2007 Sep; 17(9):731-42. PubMed ID: 17700362
[TBL] [Abstract][Full Text] [Related]
12. Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma.
Miki Y; Suzuki T; Kitada K; Yabuki N; Shibuya R; Moriya T; Ishida T; Ohuchi N; Blumberg B; Sasano H
Cancer Res; 2006 Jan; 66(1):535-42. PubMed ID: 16397270
[TBL] [Abstract][Full Text] [Related]
13. Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues.
Hines WC; Fajardo AM; Joste NE; Bisoffi M; Griffith JK
Mol Cancer Res; 2005 Sep; 3(9):503-9. PubMed ID: 16179497
[TBL] [Abstract][Full Text] [Related]
14. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
15. FT-Raman, FT-IR spectroscopy and PIXE analysis applied to gallstones specimens.
Paluszkiewicz C; Kwiatek WM; Gałka M; Sobieraj D; Wentrup-Byrne E
Cell Mol Biol (Noisy-le-grand); 1998 Feb; 44(1):65-73. PubMed ID: 9551638
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
[TBL] [Abstract][Full Text] [Related]
17. Forensic analysis of architectural finishes using fourier transform infrared and Raman spectroscopy, part I: the resin bases.
Bell SE; Fido LA; Speers SJ; Armstrong WJ; Spratt S
Appl Spectrosc; 2005 Nov; 59(11):1333-9. PubMed ID: 16316510
[TBL] [Abstract][Full Text] [Related]
18. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
19. FT-IR, NIR-FT-Raman and gas phase infrared spectra of 3-aminoacetophenone by density functional theory and ab initio Hartree-Fock calculations.
Subramanian MK; Anbarasan PM; Ilangovan V; Babu SM
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Nov; 71(1):59-67. PubMed ID: 18178129
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
